Skip to main content

Advertisement

Log in

Recent Concepts of Autoimmune Pancreatitis and IgG4-Related Disease

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

Recent studies suggested the existence of two subtypes of autoimmune pancreatitis (AIP): type 1 related with IgG4 (lymphoplasmacytic sclerosing pancreatitis; LPSP) and type 2 related with a granulocytic epithelial lesion (idiopathic duct-centric chronic pancreatitis; IDCP). Apart from type 2 AIP, the pathological features of type 1 AIP with increased serum IgG4/IgE levels, abundant infiltration of IgG4+ plasmacytes and lymphocytes, fibrosis, and steroid responsiveness are suggestive of abnormal immunity such as allergy or autoimmunity. Moreover, the patients with type 1 AIP often have extrapancreatic lesions such as sclerosing cholangitis, sclerosing sialadenitis, or retroperitoneal fibrosis showing similar pathological features. Based on these findings, many synonyms have been proposed for these conditions, such as “multifocal idiopathic fibrosclerosis”, “IgG4-related autoimmune disease”, “IgG4-related sclerosing disease”, “IgG4-related plasmacytic disease”, and “IgG4-related multiorgan lymphoproliferative syndrome”, all of which may refer to the same conditions. Therefore, the Japanese Research Committee for “Systemic IgG4-related Sclerosing Disease” proposed a disease concept and clinical diagnostic criteria based on the concept of multifocal fibrosclerosis in 2009, in which the term “IgG4-related disease” was appointed as a minimal consensus on these conditions. Although the significance of IgG4 in the development of “IgG4-related disease” remains unclear, we have proposed a hypothesis for the development of type 1 AIP, one of the IgG4-related disease. The concept and diagnostic criteria of “IgG4-related disease” will be changed in accordance with future studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

AIP:

Autoimmune pancreatitis

ANA:

Anti-nuclear antibody

CA-II:

Carbonic anhydrase-II

CTLA-4 :

Cytotoxic T lymphocyte antigen-4

ERCP:

Endoscopic retrograde cholangiopancreatography

FCRL:

Fc-receptor-like

IFN-γ:

Interferon-γ

IL-4:

Interleukin-4

LF:

Lactoferrin

LPSP:

Lymphoplasmacytic sclerosing pancreatitis

MD:

Mikulicz disease

MHC:

Major histocompatibility complex

MOLPS:

Multiorgan lymphoproliferative disease

PBP:

Plasminogen-binding protein

SjS:

Sjögren’s syndrome

PSC:

Primary sclerosing cholangitis

RF:

Rheumatoid factor

SIPS:

IgG4-systemic plasmacytic syndrome

SLE:

Systemic lupus erythematosus

Treg:

Regulatory T cell

UBR2:

Ubiquitin-protein ligase E3 component n-recognin 2

References

  1. Sarles H, Sarles JC, Muratore R, Guien C (1961) Chronic inflammatory sclerosis of the pancreas—an autonomous pancreatic disease? Am J Dig Dis 6:688–698

    Article  PubMed  CAS  Google Scholar 

  2. Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N (1995) Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 40:1561–1568

    Article  PubMed  CAS  Google Scholar 

  3. Hamano H, Kawa S, Horiuchi A et al (1995) High serum IgG4 concentrations in patients with sclerosing pancreatitis. New Engl J Med 344:732–738

    Article  Google Scholar 

  4. Okazaki K, Uchida K, Chiba T (2001) Recent concept of autoimmune-related pancreatitis. J Gastroenterol 36:293–302

    Article  PubMed  CAS  Google Scholar 

  5. Okazaki K (2006) Autoimmune pancreatitis—recent concept. In: Parviz M (ed) Target organ toxicology series, Toxicology of the pancreas. Taylor & Francis, Boca Raton, pp 59–73

    Google Scholar 

  6. Pickartz T, Mayerle J, Lerch M (2007) Autoimmune pancreatitis. Nat Clin Pract Gastroenterol Hepatol 4:314–323

    Article  PubMed  CAS  Google Scholar 

  7. Kawaguchi K, Koike M, Tsuruta K, Okamoto A, Tabata I, Fujita N (1991) Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol 22:387–395

    Article  PubMed  CAS  Google Scholar 

  8. Kamisawa T, Funata N, Hayashi Y et al (2003) A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 38:982–984

    Article  PubMed  CAS  Google Scholar 

  9. Comings DE et al (1967) Familial multifocal fibrosclerosis. Ann Intern Med 66:884–892

    PubMed  CAS  Google Scholar 

  10. Chari ST, Kloeppel G, Zhang L et al (2010) Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document. Pancreas 39:549–554

    Article  PubMed  CAS  Google Scholar 

  11. Mikulicz J (1892) Über eine eigenartige symmetrishe Erkrankung der Tränen und Mundspeicheldrüsen. Beitr z Chir Fesrschr f Theodor Billroth, Stuttgart, pp 610–630

    Google Scholar 

  12. Okazaki K, Kawa S, Kamisawa T et al (2006) Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol 41:626–631

    Article  PubMed  Google Scholar 

  13. Kamisawa T, Okamoto A (2006) Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease. J Gastroenterol 41:613–625

    Article  PubMed  CAS  Google Scholar 

  14. Yamamoto M, Takahashi H, Ohara M et al (2006) A new conceptualization for Mikulicz’s disease as an IgG4-related plasmacytic disease. Mod Rheumatol 16:335–340

    Article  PubMed  CAS  Google Scholar 

  15. Masaki Y, Dong L, Kurose N et al (2009) Proposal for a new clinical entity, IgG4-positive multi-organ lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis 68:1310–1315

    Article  PubMed  CAS  Google Scholar 

  16. Notohara K, Burgart LJ, Yadav D et al (2003) Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinico-pathologic features of 35 cases. Am J Surg Pathol 27:1119–1127

    Article  PubMed  Google Scholar 

  17. Zamboni G, Lüttges J, Capelli P et al (2004) Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch 445:552–563

    Article  PubMed  Google Scholar 

  18. Kamisawa T, Funata N, Hayashi Y et al (2003) Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut 52:683–687

    Article  PubMed  CAS  Google Scholar 

  19. Saegusa H, Momose M, Kawa S et al (2003) Hilar and pancreatic gallium-67 accumulation is characteristic feature of autoimmune pancreatitis. Pancreas 27:20–251

    Article  PubMed  Google Scholar 

  20. Erkelens GW, Vleggaar FP, Lesterhuis W et al (1999) Sclerosing pancreato-cholangitis responsive to steroid therapy. Lancet 354:43–44

    Article  PubMed  CAS  Google Scholar 

  21. Nakazawa T, Ohara H, Yamada T (2001) Atypical primary sclerosing cholangitis cases associated with unusual pancreatitis. Hepatogastroenterology 48:625–630

    PubMed  CAS  Google Scholar 

  22. Hamano H, Kawa S, Ochi Y et al (2002) Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet 359:1403–1404

    Article  PubMed  Google Scholar 

  23. Takeda S, Haratake J, Kasai T et al (2004) IgG4-associated idiopathic tubulointerstitial nephritis complicating autoimmune pancreatitis. Nephrol Dial Transplant 19:474–476

    Article  PubMed  Google Scholar 

  24. Uchiyama-Tanaka Y, Mori Y, Kimura T et al (2004) Acute tubulointerstitial nephritis associated with autoimmune-related pancreatitis. Am J Kidney Dis 43:e18–e25

    Article  PubMed  Google Scholar 

  25. Shimatsu A, Oki Y, Fujisawa I et al (2009) Pituitary and stalk lesions (infundibulo-hypophysitis) associated with immunoglobulin G4-related systemic disease: an emerging clinical entity. Endocr J 56:1033–1041

    Article  PubMed  Google Scholar 

  26. Komatsu K, Hamano H, Ochi Y et al (2005) High prevalence of hypothyroidism in patients with autoimmune pancreatitis. Dig Dis Sci 50:1052–1057

    Article  PubMed  Google Scholar 

  27. Yoshimura Y, Takeda S, Ieki Y et al (2006) IgG4-associated prostatitis complicating autoimmune pancreatitis. Intern Med 45:897–901

    Article  PubMed  Google Scholar 

  28. Okazaki K, Uchida K, Matsushita M et al (2007) How to diagnose autoimmune pancreatitis by the revised Japanese clinical criteria. J Gastroenterol 42(Suppl 18):32–38

    Article  PubMed  Google Scholar 

  29. Ohara H, Nakazawa T, Sano H et al (2005) Systemic extrapancreatic lesions associated with autoimmune pancreatitis. Pancreas 31:232–237

    Article  PubMed  Google Scholar 

  30. Hamano H, Arakura N, Muraki T et al (2006) Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J Gastroenterol 41:1197–1205

    Article  PubMed  Google Scholar 

  31. Kawa S, Okazaki K, Kamisawa T et al (2010) Japanese consensus guidelines for management of autoimmune pancreatitis: II. Extrapancreatic lesions, differential diagnosis. J Gastroenterol 45:355–369

    Article  PubMed  Google Scholar 

  32. Okazaki K, Kawa S, Kamisawa T et al (2009) Japanese clinical guidelines for autoimmune pancreatitis. Pancreas 38:849–866

    Article  PubMed  Google Scholar 

  33. Okazaki K, Kawa S, Kamisawa T et al (2010) Japanese consensus guidelines for management of autoimmune pancreatitis: I. Concept and diagnosis of autoimmune pancreatitis. J Gastroenterol 45:249–265

    Article  PubMed  Google Scholar 

  34. Kamisawa T, Okazaki K, Kawa S et al (2010) Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol 45:471–477

    Article  PubMed  CAS  Google Scholar 

  35. Okazaki K, Uchida K, Research Committee Members (2009) Proposal of the concept and diagnostic criteria of IgG4-related disease. Annual reports of research committee of intractable diseases supported by Ministry of Health, Labour and Welfare of Japan, pp 25–30 (in Japanese)

  36. Masaki Y, Sugai S, Umehara H (2010) IgG4-related diseases including Mikulicz’s disease and sclerosing pancreatitis: diagnostic insights. J Rheumatol 37:1380–1385

    Article  PubMed  CAS  Google Scholar 

  37. Kawa S, Ota M, Yoshizawa K et al (2002) HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population. Gastroenterology 122:1264–1269

    Article  PubMed  Google Scholar 

  38. Park do H, Kim MH, Oh HB (2008) Substitution of aspartic acid at position 57 of the DQbeta1 affects relapse of autoimmune pancreatitis. Gastroenterology 134:440–446

    Article  PubMed  Google Scholar 

  39. Kochi Y, Yamada R, Suzuki A et al (2005) A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat Genet 37(5):478–485

    Article  PubMed  CAS  Google Scholar 

  40. Umemura T, Ota M, Hamano H, Katsuyama Y, Kiyosawa K, Kawa S (2006) Genetic association of Fc receptor-like 3 polymorphisms with autoimmune pancreatitis in Japanese patients. Gut 55(9):1367–1368

    Article  PubMed  CAS  Google Scholar 

  41. Umemura T, Katsuyama Y, Hamano H et al (2009) Association analysis of Toll-like receptor 4 polymorphisms with autoimmune pancreatitis. Hum Immunol 70:742–746

    Article  PubMed  CAS  Google Scholar 

  42. Chang MC, Chang YT, Tien YW et al (2007) T-cell regulatory gene CTLA-4 polymorphism/haplotype association with autoimmune pancreatitis. Clin Chem 53(9):1700–1705

    Article  PubMed  CAS  Google Scholar 

  43. Umemura T, Ota M, Hamano H et al (2008) Association of autoimmune pancreatitis with cytotoxic T-lymphocyte antigen 4 gene polymorphisms in Japanese patients. Am J Gastroenterol 103(3):588–594

    Article  PubMed  CAS  Google Scholar 

  44. Ueda H, Howson JM, Esposito L et al (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423(6939):506–511

    Article  PubMed  CAS  Google Scholar 

  45. Roitt I (1997) Antibodies. In: Roitt I (ed) Roitt’s essential immunology, 9th edn. Blackwell Science, London, pp 43–62

    Google Scholar 

  46. Taguchi M, Kihara Y, Nagashio Y, Yamamoto M, Otsuki M, Harada M (2009) Decreased production of immunoglobulin M and A in autoimmune pancreatitis. J Gastroenterol 44:1133–1139

    Article  PubMed  CAS  Google Scholar 

  47. Robinson DS, Larche M, Durham SR (2004) Tregs and allergic disease. J Clin Invest 114(10):1389–1397

    PubMed  CAS  Google Scholar 

  48. van der Neut Kolfschoten M, Schuurman J, Losen M et al (2007) Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science 317(5844):1554–1557

    Article  PubMed  Google Scholar 

  49. Kawa S, Kitahara K, Hamano H et al (2008) A novel immunoglobulin-immunoglobulin interaction in autoimmunity. PLoS ONE 3(2):e1637

    Article  PubMed  Google Scholar 

  50. Cornell LD, Chicano SL, Deshpande V et al (2007) Pseudotumors due to IgG4 immune-complex tubulointerstitial nephritis associated with autoimmune pancreatocentric disease. Am J Surg Pathol 31(10):1586–1597

    Article  PubMed  Google Scholar 

  51. Muraki T, Hamano H, Ochi Y et al (2006) Autoimmune pancreatitis and complement activation system. Pancreas 32(1):16–21

    Article  PubMed  Google Scholar 

  52. Uchida K, Okazaki K, Konishi Y et al (2000) Clinical analysis of autoimmune-related pancreatitis. Am J Gastroenterol 95(10):2788–2794

    Article  PubMed  CAS  Google Scholar 

  53. Okazaki K, Uchida K, Ohana M et al (2000) Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology 118(3):573–581

    Article  PubMed  CAS  Google Scholar 

  54. Nishi H, Tojo A, Onozato ML et al (2007) Anti-carbonic anhydrase II antibody in autoimmune pancreatitis and tubulointerstitial nephritis. Nephrol Dial Transplant 22(4):1273–1275

    Article  PubMed  Google Scholar 

  55. Aparisi L, Farre A, Gomez-Cambronero L et al (2005) Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: relevance for diagnosis of autoimmune pancreatitis. Gut 54(5):703–709

    Article  PubMed  CAS  Google Scholar 

  56. Nishimori I, Miyaji E, Morimoto K, Nagao K, Kamada M, Onishi S (2005) Serum antibodies to carbonic anhydrase IV in patients with autoimmune pancreatitis. Gut 54(2):274–281

    Article  PubMed  CAS  Google Scholar 

  57. Asada M, Nishio A, Uchida K et al (2006) Identification of a novel autoantibody against pancreatic secretory trypsin inhibitor in patients with autoimmune pancreatitis. Pancreas 33(1):20–26

    Article  PubMed  CAS  Google Scholar 

  58. Endo T, Takizawa S, Tanaka S et al (2009) Amylase alpha-2A autoantibodies: novel marker of autoimmune pancreatitis and fulminant type 1 diabetes. Diabetes 58(3):732–737

    Article  PubMed  CAS  Google Scholar 

  59. Takizawa S, Endo T, Wanjia X, Tanaka S, Takahashi M, Kobayashi T (2009) HSP 10 is a new autoantigen in both autoimmune pancreatitis and fulminant type 1 diabetes. Biochem Biophys Res Commun 386(1):192–196

    Article  PubMed  CAS  Google Scholar 

  60. Frulloni L, Lunardi C, Simone R et al (2009) Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med 361(22):2135–2142

    Article  PubMed  CAS  Google Scholar 

  61. Nishimori I, Bratanova T, Toshkov I et al (1995) Induction of experimental autoimmune sialoadenitis by immunization of PL/J mice with carbonic anhydrase II. J Immunol 154(9):4865–4873

    PubMed  CAS  Google Scholar 

  62. Ueno Y, Ishii M, Takahashi S, Igarashi T, Toyota T, LaRusso NF (1998) Different susceptibility of mice to immune-mediated cholangitis induced by immunization with carbonic anhydrase II. Lab Invest 78(5):629–637

    PubMed  CAS  Google Scholar 

  63. Kountouras J, Zavos C, Gavalas E, Tzilves D (2007) Challenge in the pathogenesis of autoimmune pancreatitis: potential role of helicobacter pylori infection via molecular mimicry. Gastroenterology 133(1):368–369

    Article  PubMed  Google Scholar 

  64. Kountouras J, Zavos C, Chatzopoulos D (2005) A concept on the role of Helicobacter pylori infection in autoimmune pancreatitis. J Cell Mol Med 9(1):196–207

    Article  PubMed  CAS  Google Scholar 

  65. Guarneri F, Guarneri C, Benvenga S (2005) Helicobacter pylori and autoimmune pancreatitis: role of carbonic anhydrase via molecular mimicry? J Cell Mol Med 9(3):741–744

    Article  PubMed  CAS  Google Scholar 

  66. McGeachy MJ, Cua DJ (2007) The link between IL-23 and Th17 cell-mediated immune pathologies. Semin Immunol 19(6):372–376

    Article  PubMed  CAS  Google Scholar 

  67. Oukka M (2007) Interplay between pathogenic Th17 and regulatory T cells. Ann Rheum Dis 66(Suppl 3):iii87–iii90

    Article  PubMed  CAS  Google Scholar 

  68. Yamamoto M, Harada S, Ohara M et al (2005) Clinical and pathological differences between Mikulicz’s disease and Sjogren’s syndrome. Rheumatology 44(2):227–234

    Article  PubMed  CAS  Google Scholar 

  69. Zen Y, Fujii T, Harada K et al (2007) Th2 and regulatory immune reactions are increased in immunoglobulin G4-related sclerosing pancreatitis and cholangitis. Hepatology 45(6):1538–1546

    Article  PubMed  CAS  Google Scholar 

  70. Uchida K, Okazaki K, Nishi T et al (2002) Experimental immune-mediated pancreatitis in neonatally thymectomized mice immunized with carbonic anhydrase II and lactoferrin. Lab Invest 82(4):411–424

    Article  PubMed  CAS  Google Scholar 

  71. Ajjan RA, McIntosh RS, Waterman EA et al (1998) Analysis of the T-cell receptor Valpha repertoire and cytokine gene expression in Sjogren’s syndrome. Br J Rheumatol 37(2):179–185

    Article  PubMed  CAS  Google Scholar 

  72. Dienes HP, Lohse AW, Gerken G et al (1997) Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis. Virchows Arch 431(2):119–124

    Article  PubMed  CAS  Google Scholar 

  73. Valencia X, Lipsky PE (2007) CD4+CD25+FoxP3+ regulatory T cells in autoimmune diseases. Nat Clin Pract Rheumatol 3(11):619–626

    Article  PubMed  CAS  Google Scholar 

  74. Gottenberg JE, Lavie F, Abbed K et al (2005) CD4 CD25high regulatory T cells are not impaired in patients with primary Sjogren’s syndrome. J Autoimmun 24(3):235–242

    Article  PubMed  CAS  Google Scholar 

  75. Miyoshi H, Uchida K, Taniguchi T et al (2008) Circulating naive and CD4+CD25high regulatory T cells in patients with autoimmune pancreatitis. Pancreas 36(2):133–140

    Article  PubMed  CAS  Google Scholar 

  76. Stanley JR, Amagai M (2006) Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome. N Engl J Med 355(17):1800–1810

    Article  PubMed  CAS  Google Scholar 

  77. Fujii H, Nakatani K, Arita N et al (2003) Internalization of antibodies by endothelial cells via fibronectin implicating a novel mechanism in lupus nephritis. Kidney Int 64(5):1662–1670

    Article  PubMed  CAS  Google Scholar 

  78. Aalberse RC, Stapel SO, Schuurman J, Rispens T (2009) Immunoglobulin G4: an odd antibody. Clin Exp Allergy 39(4):469–477

    Article  PubMed  CAS  Google Scholar 

  79. Ruiter B, Knol EF, van Neerven RJ et al (2007) Maintenance of tolerance to cow’s milk in atopic individuals is characterized by high levels of specific immunoglobulin G4. Clin Exp Allergy 37(7):1103–1110

    Article  PubMed  CAS  Google Scholar 

  80. Hussain R, Poindexter RW, Ottesen EA (1992) Control of allergic reactivity in human filariasis. Predominant localization of blocking antibody to the IgG4 subclass. J Immunol 148(9):2731–2737

    PubMed  CAS  Google Scholar 

  81. Yazdanbakhsh M, van den Biggelaar A, Maizels RM (2001) Th2 responses without atopy: immunoregulation in chronic helminth infections and reduced allergic disease. Trends Immunol 22(7):372–377

    Article  PubMed  CAS  Google Scholar 

  82. Sakaguchi S, Fukuma K, Kuribayashi K, Masuda T (1985) Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J Exp Med 161(1):72–87

    Article  PubMed  CAS  Google Scholar 

  83. Demols A, Le Moine O, Desalle F, Quertinmont E, Van Laethem JL, Deviere J (2000) CD4(+)T cells play an important role in acute experimental pancreatitis in mice. Gastroenterology 118(3):582–590

    Article  PubMed  CAS  Google Scholar 

  84. Vallance BA, Hewlett BR, Snider DP, Collins SM (1998) T cell-mediated exocrine pancreatic damage in major histocompatibility complex class II-deficient mice. Gastroenterology 115(4):978–987

    Article  PubMed  CAS  Google Scholar 

  85. Sakaguchi Y, Inaba M, Tsuda M et al (2008) The Wistar Bonn Kobori rat, a unique animal model for autoimmune pancreatitis with extrapancreatic exocrinopathy. Clin Exp Immunol 152(1):1–12

    Article  PubMed  CAS  Google Scholar 

  86. Marth T, Strober W, Kelsall BL (1996) High dose oral tolerance in ovalbumin TCR-transgenic mice: systemic neutralization of IL-12 augments TGF-beta secretion and T cell apoptosis. J Immunol 157(6):2348–2357

    PubMed  CAS  Google Scholar 

  87. Hahm KB, Im YH, Lee C et al (2000) Loss of TGF-beta signaling contributes to autoimmune pancreatitis. J Clin Invest 105(8):1057–1065

    Article  PubMed  CAS  Google Scholar 

  88. Kusuda T, Uchida K, Satoi S et al (2010) Idiopathic duct-centric pancreatitis (IDCP) with immunological studies. Intern Med 49(23):2569–2575

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

This study was partly supported by a Grant-in-Aid for Scientific Research from the Ministry of Culture and Science of Japan (20590810) and a Grant-in-Aid for “Research for Intractable Disease” Program from the Ministry of Health, Labor and Welfare of Japan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kazuichi Okazaki.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Okazaki, K., Uchida, K., Miyoshi, H. et al. Recent Concepts of Autoimmune Pancreatitis and IgG4-Related Disease. Clinic Rev Allerg Immunol 41, 126–138 (2011). https://doi.org/10.1007/s12016-010-8214-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12016-010-8214-2

Keywords

Navigation